Get started
Ascendis Pharma A/S Sponsored ADRAscendis Pharma A/S Sponsored ADRAscendis Pharma A/S Sponsored ADR

Ascendis Pharma A/S Sponsored ADR

No trades
OverviewFinancialsNewsDocumentsMindsTechnicalsForecastsSeasonalsOptionsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.03 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.25 USD
Net income (FY)
‪−408.97 M‬ USD
Revenue (FY)
‪393.35 M‬ USD
Shares float
‪60.47 M‬
Beta (1Y)
0.56

About Ascendis Pharma A/S Sponsored ADR


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jan Møller Mikkelsen
Website
ascendispharma.com
Headquarters
Hellerup
Founded
2006
IPO date
Jan 28, 2015
IPO offer price
18.00 USD
Identifiers
3
ISINUS04351P1012
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Check out other big names from the same industry as ASND.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


ASND5566766
Ascendis Pharma A/S 2.25% 01-APR-2028
Yield to maturity
—
Maturity date
Apr 1, 2028

See all ASND bonds 

ETFs


IBB
iShares Biotechnology ETF
Weight
0.87%
Market value
‪72.80 M‬
USD
CGGR
Capital Group Growth ETF
Weight
0.24%
Market value
‪45.30 M‬
USD
DBXW
Xtrackers MSCI WORLD SWAP UCITS ETF Capitalisation 1C
Weight
0.37%
Market value
‪39.87 M‬
USD
XWD1
Xtrackers MSCI World Swap UCITS ETF
Weight
0.37%
Market value
‪39.87 M‬
USD
XWEH
Xtrackers MSCI WORLD SWAP UCITS ETF Capitalisation 4C
Weight
0.37%
Market value
‪39.87 M‬
USD
XSXD
Xtrackers S&P 500 Swap UCITS ETF
Weight
0.11%
Market value
‪12.42 M‬
USD
XS5G
Xtrackers S&P 500 Swap UCITS ETF
Weight
0.11%
Market value
‪12.42 M‬
USD
XSPU
Xtrackers S&P 500 SWAP UCITS ETF Capitalisation 1C
Weight
0.11%
Market value
‪12.42 M‬
USD
XS5E
Xtrackers S&P 500 Swap UCITS ETF 5C-EUR Hedged
Weight
0.11%
Market value
‪12.42 M‬
USD
FDG
American Century Focused Dynamic Growth ETF
Weight
2.80%
Market value
‪9.89 M‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.96%
Market value
‪8.55 M‬
USD

Explore more ETFs